Your session is about to expire
← Back to Search
Colonoscopy Techniques for Inflammatory Bowel Disease
N/A
Waitlist Available
Research Sponsored by Beth Israel Deaconess Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
History of UC or colonic Crohn's disease or unclassified colitis patients with or without colonic adenoma history
Mucosal lesion involves ≥ 1/3 of the colon
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately after the procedure
Awards & highlights
Study Summary
This trial is studying whether one colonoscopy technique is better than another for detecting colon cancer in patients with IBD.
Who is the study for?
This trial is for adults over 18 with a history of Ulcerative Colitis, Crohn's disease affecting the colon, or unclassified colitis lasting at least eight years, or any duration if also diagnosed with primary sclerosing cholangitis. Participants must have significant colon involvement and not had a total colectomy or recent colonoscopy.Check my eligibility
What is being tested?
The study compares two techniques to screen for cancer in patients with long-term IBD: High Definition Colonoscopy (HDC) versus Dye Spraying Chromocolonoscopy (DSC), using high-definition cameras to detect abnormal growths in the colon.See study design
What are the potential side effects?
Potential side effects may include discomfort from the procedure, reactions to dye used in DSC such as allergic responses, and risks typically associated with standard colonoscopies like bleeding or perforation.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have a history of ulcerative colitis, Crohn's disease, or unspecified colitis, with or without a history of colon polyps.
Select...
My colon lesion affects more than one-third of it.
Select...
I was diagnosed over 8 years ago or have primary sclerosing cholangitis.
Select...
I am 18 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ immediately after the procedure
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately after the procedure
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Detection rate of dysplastic lesions in High Definition White Light Colonoscopy versus Dye Spraying Chromo-colonoscopy
Secondary outcome measures
Appropriateness of reported follow up recommendations per standard guideline recommendations
Detection rate of Adenoma in both groups.
Detection rate of high-grade dysplasia in both groups.
+4 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: High Definition White Light ColonoscopyExperimental Treatment1 Intervention
Group II: Dye Spraying Chromo-colonoscopyActive Control1 Intervention
Find a Location
Who is running the clinical trial?
Beth Israel Deaconess Medical CenterLead Sponsor
837 Previous Clinical Trials
13,009,772 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have a history of ulcerative colitis, Crohn's disease, or unspecified colitis, with or without a history of colon polyps.My colon lesion affects more than one-third of it.I was diagnosed over 8 years ago or have primary sclerosing cholangitis.I have had my entire colon removed.You are allergic to the dye spray used in the study.I am unable to understand and agree to the study's details on my own.I am 18 years old or older.I have had colorectal cancer in the past.
Research Study Groups:
This trial has the following groups:- Group 1: Dye Spraying Chromo-colonoscopy
- Group 2: High Definition White Light Colonoscopy
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger